{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:36:49Z","timestamp":1790948209638,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejvs.2021.09.026","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T08:42:06Z","timestamp":1637916126000},"page":"91-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["A Systematic Review and Meta-Analysis on the Impact of High On-Treatment Platelet Reactivity on Clinical Outcomes for Patients Taking ADP Receptor Inhibitors Following Lower Limb Arterial Endovascular Intervention"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5340-2079","authenticated-orcid":false,"given":"Petar","family":"Zlatanovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1498-0316","authenticated-orcid":false,"given":"Kitty H.F.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros K.","family":"Kakkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0385-5760","authenticated-orcid":false,"given":"Christopher P.","family":"Twine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2021.09.026_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A\u00a0randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2021.09.026_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s42155-019-0079-8","article-title":"The CLEAR (Considering Leading Experts Antithrombotic Regimes around peripheral angioplasty) survey: an international perspective on antiplatelet and anticoagulant practice for peripheral arterial endovascular intervention","volume":"2","author":"Wong","year":"2019","journal-title":"CVIR Endovasc"},{"key":"10.1016\/j.ejvs.2021.09.026_bib3","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.jacc.2013.03.036","article-title":"Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: the PRECLOP study: clinical impact and optimal cutoff value of on-treatment high platelet reactivity","volume":"61","author":"Spiliopoulos","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2021.09.026_bib4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejvs.2018.06.032","article-title":"On-treatment platelet reactivity is a predictor of adverse events in peripheral artery disease patients undergoing percutaneous angioplasty","volume":"56","author":"Grifoni","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2021.09.026_bib5","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet therapy--the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejvs.2021.09.026_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2020.11.001","article-title":"Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy","volume":"315","author":"Weissler","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejvs.2021.09.026_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/bjs.11384","article-title":"Umbrella review and meta-analysis of antiplatelet therapy for peripheral artery disease","volume":"107","author":"Ambler","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2021.09.026_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejvs.2020.03.010","article-title":"Antiplatelet and anticoagulant use in randomised trials of patients undergoing endovascular intervention for peripheral arterial disease: systematic review and narrative synthesis","volume":"60","author":"Qureshi","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2021.09.026_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejvs.2021.09.026_bib10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Working Group on High On-Treatment Platelet Reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2021.09.026_bib11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/jth.12538","article-title":"Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis","volume":"12","author":"Wisman","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ejvs.2021.09.026_bib12","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et\u00a0al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp [Accessed January 2018]."},{"key":"10.1016\/j.ejvs.2021.09.026_bib13","series-title":"How to GRADE the Quality of the Evidence","author":"Ryan","year":"2016"},{"key":"10.1016\/j.ejvs.2021.09.026_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/0953710021000057866","article-title":"Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients","volume":"13","author":"Ziegler","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.ejvs.2021.09.026_bib15","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00270-013-0577-3","article-title":"Clopidogrel responsiveness in patients undergoing peripheral angioplasty","volume":"36","author":"Pastromas","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2021.09.026_bib16","first-page":"474","article-title":"In\u00a0vivo and protease-activated receptor-1-mediated platelet activation but not response to antiplatelet therapy predict two-year outcomes after peripheral angioplasty with stent implantation","volume":"111","author":"Gremmel","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejvs.2021.09.026_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jvs.2014.03.293","article-title":"Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease","volume":"60","author":"Guo","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2021.09.026_bib18","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s00270-014-0852-y","article-title":"Initial experience with ticagrelor in patients with critical limb ischemia and high on-clopidogrel platelet reactivity undergoing complex peripheral endovascular procedures","volume":"37","author":"Spiliopoulos","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ejvs.2021.09.026_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1024\/0301-1526\/a000510","article-title":"High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease","volume":"45","author":"Bernlochner","year":"2016","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2021.09.026_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejvs.2019.02.011","article-title":"CYP2C19 polymorphism is associated with amputation rates in patients taking clopidogrel after endovascular intervention for critical limb ischaemia","volume":"58","author":"Lee","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2021.09.026_bib21","first-page":"1","article-title":"Impact of high on-treatment platelet reactivity after angioplasty in patients with peripheral arterial disease","volume":"7","author":"Busch","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.ejvs.2021.09.026_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/0003-4819-115-4-256","article-title":"Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI), phase II trial","volume":"115","author":"Bovill","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejvs.2021.09.026_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/eurheartj\/ehaa824","article-title":"Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey","volume":"42","author":"Cao","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2021.09.026_bib24","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2005.07.056","article-title":"Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2021.09.026_bib25","first-page":"295","article-title":"Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation","volume":"59","author":"Barragan","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2021.09.026_bib26","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.jacc.2004.10.079","article-title":"Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study","volume":"45","author":"Ajzenberg","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2021.09.026_bib27","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.jacc.2007.01.094","article-title":"Impact of platelet reactivity after clopidogrel administration on drug eluting stent thrombosis","volume":"49","author":"Buonamici","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2021.09.026_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2021.09.026_bib29","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic\u00a0limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2021.09.026_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ejcts\/ezx334","article-title":"ESC Scientific Document Group. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"53","author":"Valgimigli","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ejvs.2021.09.026_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121620","article-title":"Evaluation of clinical risk factors to predict high on-treatment platelet reactivity and outcome in patients with stable coronary artery disease (predict-stable)","volume":"10","author":"Droppa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejvs.2021.09.026_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1538574416638759","article-title":"Coagulation, fibrinolysis, and platelet activation following open surgical or percutaneous angioplasty revascularization for symptomatic lower limb chronic ischemia","volume":"50","author":"Rayt","year":"2016","journal-title":"Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2021.09.026_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.2020.12443","article-title":"Effect of genotype-guided oral P2Y12 inhibitor selection vs conventional clopidogrel therapy on ischemic outcomes after percutaneous coronary intervention: the TAILOR-PCI randomized clinical trial","volume":"324","author":"Pereira","year":"2020","journal-title":"JAMA"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588421007656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588421007656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:56:54Z","timestamp":1761047814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588421007656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1078588421007656"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2021.09.026","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review and Meta-Analysis on the Impact of High On-Treatment Platelet Reactivity on Clinical Outcomes for Patients Taking ADP Receptor Inhibitors Following Lower Limb Arterial Endovascular Intervention","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2021.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society for Vascular Surgery. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}